Kidney Research UK, has been pivotal in fostering relationships between the life sciences, academia and the NHS in recent years which is has enabled a culture of collaboration and is paving the way for a growing number of Complex and Innovative Design (CID) trials.
Published: 20 January 2020
The NIHR research infrastructure supports the delivery of complex and innovative clinical trials.
Complex and Innovative Design (CID) trials have the potential to shorten the drug development time line and get new treatments to patients faster. This is an attractive prospect for research charities like Kidney Research UK which have a strong connection with their patient community.
To that end, Kidney Research UK, has been pivotal in fostering relationships between the life sciences, academia and the NHS in recent years. By supporting dialogue between these sectors, it has enabled a culture of collaboration which has made the UK a prime destination for renal research and is paving the way for a growing number of Complex and Innovative Design (CID) trials.
In these two videos, representatives from Kidney Research UK highlight some of the UK's selling points for renal research. From harnessing the NHS's data capabilities, to connected clinical communities, to the creation of research registries and bio repositories the message is clear - the UK is a world leader in renal research.
Jeremy Hughes, Kidney Research UK
Jeremy Hughes is the Chair of Kidney Research UK and the Chair of the UK Kidney Research Consortium.
Michael Nation, Kidney Research UK
Michael Nation is Development Director at Kidney Research UK (KRUK).
- Watch more related videos our Complex and innovative trial design and delivery playlist on our YouTube channel: NIHRtv.
- Visit our Delivering complex and innovative clinical trials web page to learn more about NIHR support available for complex and innovative trials.